The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.
Today's Daily Dose brings you news about Menlo's Serlopitant trial results, Novavax's update on its efforts to develop a novel vaccine against coronavirus disease COVID-19, Oramed's oral insulin trial results and Vir Biotech's entry into coronavirus vaccine development space.
Enlivex Therapeutics Ltd. (ENLV), a clinical-stage immunotherapy company, has a couple of events lined up for this year.
Nemaura Medical Inc. (NMRD), which implemented a 1-for-10 reverse split on December 5, 2019, to regain compliance with NASDAQ, has gained more than 65 percent so far this year.
Today's Daily Dose brings you news about IMV's ovarian cancer trial results, reports of Iovance considering a possible sale, Nemaura's head -to-head study with a major Glucose Monitoring System, and disappointing trial results of Vanda and Supernus.
President Donald Trump said Tuesday that markets will crash like never before if he loses the presidential election. Trump, who is on a two-day tour of India, made the remark during his interaction with CEOs of major Indian companies in New Delhi.
Shares of Vaxart Inc. (VXRT) have gained an impressive 265 percent so far this year on hopes of a vaccine for the novel coronavirus.
Today's Daily Dose brings you news about NGM Biopharma's phase II NASH study results, Moderna's Coronavirus program, COCRYSTAL's focus on COVID-19 coronavirus and norovirus, Lipocine's update on the New Drug Application of TLANDO, growing woes of Mallinckrodt, and Takeda Pharma's date with FDA, among others.
U.S. President Donald Trump on Monday announced more than $3 billion of defense deals with India for helicopters and other military equipment on his arrival for a two-day tour of the South Asian country. "I'm pleased to announce that tomorrow our representatives will sign deals to sell over $3 billion, in the absolute finest state of the art military helicopters and other equipment to the Indian
Soligenix Inc. (SNGX), a late-stage biopharmaceutical company developing products to treat rare diseases, has multiple potential value drivers, making the stock worth watching.